190 related articles for article (PubMed ID: 31301015)
1. Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data.
Moran M; Nickens D; Adcock K; Bennetts M; Desscan A; Charnley N; Fife K
Target Oncol; 2019 Aug; 14(4):405-416. PubMed ID: 31301015
[TBL] [Abstract][Full Text] [Related]
2. Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.
Tucci M; Mandarà M; Giuliani J; Durante E; Buttigliero C; Turco F; Palesandro E; Campisi I; Singh N; Muraro M; Munoz F; Fiorica F
Cancer Treat Rev; 2024 Jun; 127():102745. PubMed ID: 38723394
[TBL] [Abstract][Full Text] [Related]
3. Real-World Progression-Free Survival as an Endpoint in Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Real-World Data.
Mhatre SK; Machado RJM; Ton TGN; Trinh H; Mazieres J; Rittmeyer A; Bretscher MT
Clin Pharmacol Ther; 2023 Dec; 114(6):1313-1322. PubMed ID: 37696652
[TBL] [Abstract][Full Text] [Related]
4. Utilization of anonymization techniques to create an external control arm for clinical trial data.
Mehtälä J; Ali M; Miettinen T; Partanen L; Laapas K; Niemelä PT; Khorlo I; Ström S; Kurki S; Vapalahti J; Abdelgawwad K; Leinonen JV
BMC Med Res Methodol; 2023 Nov; 23(1):258. PubMed ID: 37925415
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
van Nassau SCMW; Bol GM; van der Baan FH; Roodhart JML; Vink GR; Punt CJA; May AM; Koopman M; Derksen JWG
Curr Treat Options Oncol; 2024 Apr; 25(4):405-426. PubMed ID: 38367182
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of clinical trial and real-world data in patients with diabetic kidney disease.
Kurki S; Halla-Aho V; Haussmann M; Lähdesmäki H; Leinonen JV; Koskinen M
Sci Rep; 2024 Jan; 14(1):1731. PubMed ID: 38243002
[TBL] [Abstract][Full Text] [Related]
7. Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials.
Wong SE; Quinn DI; Bjarnason GA; North SA; Sridhar SS
Am J Clin Oncol; 2020 Aug; 43(8):559-566. PubMed ID: 32398404
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Metformin on Recurrence Risk and Long-Term Survival in Patients with Diabetes and Renal Cell Carcinoma.
Xu K; Ying Y
Altern Ther Health Med; 2024 Apr; 30(4):60-65. PubMed ID: 37883777
[TBL] [Abstract][Full Text] [Related]
9. Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence.
Gross-Goupil M; Bodnar L; Campbell MT; Michael A; Venugopal B; Żołnierek J; Dutailly P; Procopio G; Albiges L
Clin Genitourin Cancer; 2024 Feb; 22(1):84-97. PubMed ID: 38101983
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis.
Moraes FCA; Vilbert M; Alves VFC; de Oliveira Almeida G; Priantti JN; Madeira T; Stecca C; Fernandes MR; Dos Santos NPC
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139411
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps.
Gomes M; Turner AJ; Sammon C; Dawoud D; Ramagopalan S; Simpson A; Siebert U
Value Health; 2024 May; 27(5):623-632. PubMed ID: 38369282
[TBL] [Abstract][Full Text] [Related]
12. Considerations for pooling real-world data as a comparator cohort to a single arm trial: a simulation study on assessment of heterogeneity.
Backenroth D; Royce T; Pinheiro J; Samant M; Humblet O
BMC Med Res Methodol; 2023 Aug; 23(1):193. PubMed ID: 37620758
[TBL] [Abstract][Full Text] [Related]
13. Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma.
Sanchez Alvarez J; Jaber M; Blanchet Zumofen MH
Oncol Ther; 2023 Dec; 11(4):495-511. PubMed ID: 37851321
[TBL] [Abstract][Full Text] [Related]
14. [Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions(2): to improve the extrapolation of efficacy].
Liu ZX; Long ZL; Yang ZR; Shi SY; Xu XR; Zhao HY; Yang ZY; Fu Z; Song HB; Lin TF; Zhan SY; Sun F
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):579-584. PubMed ID: 38678356
[No Abstract] [Full Text] [Related]
15. Case study of semaglutide and cardiovascular outcomes: An application of the C
Dang LE; Fong E; Tarp JM; Clemmensen KKB; Ravn H; Kvist K; Buse JB; van der Laan M; Petersen M
J Clin Transl Sci; 2023; 7(1):e231. PubMed ID: 38028337
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of reporting quality of cohort studies using real-world data based on RECORD: systematic review.
Zhao R; Zhang W; Zhang Z; He C; Xu R; Tang X; Wang B
BMC Med Res Methodol; 2023 Jun; 23(1):152. PubMed ID: 37386371
[TBL] [Abstract][Full Text] [Related]
17. Measuring the impact of monoclonal antibody therapies.
Lim KK; Ng K; Balachandran S; Russell MD; Boalch A; Sinclair A; Coker B; Vinnakota K; Mansoor R; Douiri A; Marks LV; Sacks S
Front Med (Lausanne); 2023; 10():1256712. PubMed ID: 38046416
[TBL] [Abstract][Full Text] [Related]
18. Using real-world evidence in haematology.
Passamonti F; Corrao G; Castellani G; Mora B; Maggioni G; Della Porta MG; Gale RP
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101536. PubMed ID: 38490764
[TBL] [Abstract][Full Text] [Related]
19. Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments.
Kokkotou E; Anagnostakis M; Evangelou G; Syrigos NK; Gkiozos I
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611092
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis.
Aboseif A; Roos I; Krieger S; Kalincik T; Hersh CM
Neurol Clin; 2024 Feb; 42(1):203-227. PubMed ID: 37980116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
